Details of Protein
General Information of Protein (ID: PRT00155) | |||||
---|---|---|---|---|---|
Name | Arylamine N-acetyltransferase 1 (NAT1) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
Arylamide acetylase 1; N-acetyltransferase type 1; NAT-1; Nat1; Aac1
|
||||
Gene Name | Nat1 | Gene ID | |||
UniProt ID | |||||
Family | Transferases (EC 2) | ||||
EC Number | EC: 2.3.1.5 (Click to Show/Hide the Complete EC Tree) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MDIEAYFERIGYKNSVNKLDLATLTEVLQHQMRAVPFENLNMHCGEAMHLDLQDIFDHIV
RKKRGGWCLQVNHLLYWALTKMGFETTMLGGYVYITPVSKYSSEMVHLLVQVTISDRKYI VDSAYGGSYQMWEPLELTSGKDQPQVPAIFLLTEENGTWYLDQIRREQYVPNEEFVNSDL LEKNKYRKIYSFTLEPRVIEDFEYVNSYLQTSPASVFVSTSFCSLQTSEGVHCLVGSTFT SRRFSYKDDVDLVEFKYVNEEEIEDVLKTAFGISLERKFVPKHGELVFTI |
||||
Function | Participates in the detoxification of a plethora of hydrazine and arylamine drugs. Isoniazid, 2-aminofluorene and anisidine are preferred substrates for NAT-1. No activity with p-aminobenzoic acid (PABA) nor SMZ. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Homogeneous non-metal compounds | ||||||
Hydrazine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | Hydrazine concentration: increase (FC = 1.28) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of NAT leads to the increase of hydrazine levels compared with control group. | |||||
Lipids and lipid-like molecules | ||||||
Omega-3 Fatty Acids | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | Omega-3 Fatty Acids concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of NAT leads to the increase of omega-3 fatty Acids levels compared with control group. | |||||
Organic acids and derivatives | ||||||
s-Hexylglutathione | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | s-Hexylglutathione concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Metabolic liver disease [ICD-11: 5C90] | |||||
Details | It is reported that knockout of NAT leads to the decrease of s-hexylglutathione levels compared with control group. | |||||
Organo heterocyclic compounds | ||||||
INH-vitamin B6 (PL) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | INH-vitamin B6 (PL) concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of NAT leads to the increase of INH-vitamin B6 (PL) levels compared with control group. | |||||
INH-vitamin B6 (PLP) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | INH-vitamin B6 (PLP) concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of NAT leads to the increase of INH-vitamin B6 (PLP) levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
Acetylhydrazine | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | Acetylhydrazine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of NAT leads to the decrease of acetylhydrazine levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | Acetylhydrazine concentration: decrease | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that knockout of NAT leads to the decrease of acetylhydrazine levels compared with control group. | |||||
Isoniazid | Click to Show/Hide the Full List of Regulating Pair(s): 2 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair (1) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | Isoniazid concentration: increase (FC = 1.86) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual ... | |||||
Details | It is reported that knockout of NAT leads to the increase of isoniazid levels compared with control group. | |||||
Regulating Pair (2) |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Knockout of Nat1 | |||||
Induced Change | Isoniazid concentration: increase (FC = 2.00) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual ... | |||||
Details | It is reported that knockout of NAT leads to the increase of isoniazid levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | Deficiency of N-acetyltransferase increases the interactions of isoniazid with endobiotics in mouse liver. Biochem Pharmacol. 2017 Dec 1;145:218-225. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.